Prostaglandin Analogues
Links shared publicly online about this topic
Xalatan(R) Receives Paediatric Indication In Europe
medicalnewstoday.com — “Pfizer announced that Xalatan 0.005% (latanoprost) has been approved by the European Commission for reduction of elevated intraocular pressure (IOP) in the treatment of paediatric patients with el” View full resource at medicalnewstoday.com
Most Recently Shared on October 22, 2010 at 12:37 pm By:
Xalatan(R) Receives Paediatric Indication In Europe Pfizer announced that Xalatan 0.005% (latanoprost) has been approve.. http://dld.bz/2EMY
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on September 3, 2009 at 1:40 pm By:
eyeonfda Pharma and Health Lawyer
Merck Launches SAFLUTAN® (tafluprost) in International Markets - http://bit.ly/fUbwR
Ob/Gyn Article | Postpartum Hemorrhage
mdlinx.com — “Prostaglandin E2 Analogue Sulprostone for Treatment of Atonic Postpartum Hemorrhage” View full resource at mdlinx.com
Most Recently Shared on August 2, 2011 at 8:04 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Prostaglandin E2 Analogue Sulprostone for Treatment of Atonic Postpartum Hemorrhage: Obstetrics and Gynecology http://bit.ly/qvs4Zd #OBGYN
Sulprostone Underused for Atonic Postpartum Hemorrhage - QualityPoint Technologies
qualitypointtech.net — “The prostaglandin E2 analogue sulprostone is underused in women with severe atonic hemorrhage after vaginal delivery, French researchers maintain. Reuters Health Information” View full resource at qualitypointtech.net
Most Recently Shared on August 16, 2011 at 2:45 am By:
Sulprostone Underused for Atonic Postpartum Hemorrhage: The prostaglandin E2 analogue sulprostone is underused in ... http://t.co/vztk2gy
Study: Company sponsorship of glaucoma drug trials did not affect IOP measurements at 1 month
osnsupersite.com — “BOSTON — IOP measurements in randomized controlled trials investigating prostaglandin analogues do not appear to be affected by sponsorship of th” View full resource at osnsupersite.com
Most Recently Shared on July 10, 2009 at 3:22 pm By:
Study: Company sponsorship of #glaucoma drug trials did not affect IOP measurements at 1 month http://ow.ly/gYk1
Ob/Gyn Article | Postpartum Hemorrhage
mdlinx.com — “Prostaglandin E2 Analogue Sulprostone for Treatment of Atonic Postpartum Hemorrhage” View full resource at mdlinx.com
Most Recently Shared on August 3, 2011 at 5:21 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
Ob/Gyn Article | Postpartum Hemorrhage http://bit.ly/nDDs9I #Health #Medicine
FDA accepts Merck's SAFLUTAN NDA for standard review
news-medical.net — “Merck, known as MSD outside the United States and Canada, announced today that the New Drug Application for SAFLUTAN, Merck's investigational preservative-free prostaglandin analogue ophthalmic solution, has been accepted for standard review by the U.S. Food and Drug Administration.” View full resource at news-medical.net
Most Recently Shared on March 10, 2011 at 5:06 am By:
FDA accepts Merck's SAFLUTAN NDA for standard review: Merck, known as MSD outside the United States and Canada, ... http://bit.ly/g9Ozy6
Eyelash Growth Stimulators- Truth In Aging
truthinaging.com — “Truth in Aging delivers the honest truth about the beauty industry, informing readers about what cosmetics really work and why.” View full resource at truthinaging.com
Most Recently Shared on January 13, 2010 at 8:10 pm By:
Eyelash growth products- do they work and are they safe? The 2010 update. #eyelash http://ow.ly/W8Fg
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
medical_tweets
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
